Chengde Wu

698 total citations
26 papers, 476 citations indexed

About

Chengde Wu is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, Chengde Wu has authored 26 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Physiology and 6 papers in Organic Chemistry. Recurrent topics in Chengde Wu's work include Nitric Oxide and Endothelin Effects (14 papers), Receptor Mechanisms and Signaling (6 papers) and Pulmonary Hypertension Research and Treatments (4 papers). Chengde Wu is often cited by papers focused on Nitric Oxide and Endothelin Effects (14 papers), Receptor Mechanisms and Signaling (6 papers) and Pulmonary Hypertension Research and Treatments (4 papers). Chengde Wu collaborates with scholars based in China, United States and Canada. Chengde Wu's co-authors include Tommy A. Brock, Fiona Stavros, Richard A. F. Dixon, B. Raju, Ming Fai Chan, Ilya Okun, George W. Holland, Junmei Wang, E. Radford Decker and Karin M. Keller and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Chengde Wu

24 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengde Wu China 12 157 153 136 132 110 26 476
Bryan K. Sorensen United States 13 150 1.0× 192 1.3× 154 1.1× 46 0.3× 70 0.6× 24 512
Nathalie Ouimet Canada 7 278 1.8× 181 1.2× 134 1.0× 72 0.5× 39 0.4× 7 755
Philip D. Stein United States 18 348 2.2× 351 2.3× 267 2.0× 54 0.4× 210 1.9× 44 902
Steven A. Boyd United States 18 320 2.0× 322 2.1× 99 0.7× 29 0.2× 71 0.6× 34 739
Gary M. Ksander Switzerland 14 251 1.6× 260 1.7× 53 0.4× 114 0.9× 447 4.1× 27 1.1k
Friederike Stoll Germany 9 66 0.4× 274 1.8× 112 0.8× 39 0.3× 59 0.5× 20 531
Tram Huynh United States 15 346 2.2× 360 2.4× 84 0.6× 72 0.5× 59 0.5× 16 828
Hideyuki Adachi Japan 11 212 1.4× 266 1.7× 58 0.4× 67 0.5× 67 0.6× 25 560
Clive McCarthy United Kingdom 16 271 1.7× 255 1.7× 98 0.7× 99 0.8× 16 0.1× 29 673
Wolfgang Wostl Switzerland 9 138 0.9× 279 1.8× 49 0.4× 24 0.2× 193 1.8× 9 545

Countries citing papers authored by Chengde Wu

Since Specialization
Citations

This map shows the geographic impact of Chengde Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengde Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengde Wu more than expected).

Fields of papers citing papers by Chengde Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengde Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengde Wu. The network helps show where Chengde Wu may publish in the future.

Co-authorship network of co-authors of Chengde Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Chengde Wu. A scholar is included among the top collaborators of Chengde Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengde Wu. Chengde Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qin, Donghui, Xiaojuan Lin, Yan Chen, et al.. (2021). Discovery of Orally Bioavailable Ligand Efficient Quinazolindiones as Potent and Selective Tankyrases Inhibitors. ACS Medicinal Chemistry Letters. 12(6). 1005–1010. 7 indexed citations
2.
Wu, Chengde, et al.. (2020). Immune landscape and a promising immune prognostic model associated with TP53 in early‐stage lung adenocarcinoma. Cancer Medicine. 10(3). 806–823. 19 indexed citations
3.
Dong, Jiaqiang, et al.. (2020). Preclinical evaluation of LX-086, a small molecule as a selective inhibitor of PI3K.. Journal of Clinical Oncology. 38(15_suppl). e15662–e15662. 1 indexed citations
4.
Dong, Jiaqiang, Jing Jin, Xi Tan, et al.. (2020). Discovery of 3-Quinazolin-4(3H)-on-3-yl-2,N-dimethylpropanamides as Orally Active and Selective PI3Kα Inhibitors. ACS Medicinal Chemistry Letters. 11(7). 1463–1469. 7 indexed citations
5.
Wu, Chengde, Neng‐Yang Shih, Qi Li, et al.. (2018). Discovery of dimethyl pent-4-ynoic acid derivatives, as potent and orally bioavailable DGAT1 inhibitors that suppress body weight in diet-induced mouse obesity model. Bioorganic & Medicinal Chemistry Letters. 28(10). 1686–1692. 4 indexed citations
6.
Hunt, Rachel, Lei Fan, Tao Hu, et al.. (2010). Design, Synthesis, and Structure−Activity Relationships of Novel Bicyclic Azole-amines as Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5. Journal of Medicinal Chemistry. 53(19). 7107–7118. 23 indexed citations
7.
Wang, Junmei, George A. Krudy, Xiang‐Qun Xie, Chengde Wu, & George W. Holland. (2007). Genetic Algorithm‐Optimized QSPR Models for Bioavailability, Protein Binding, and Urinary Excretion.. ChemInform. 38(10). 1 indexed citations
8.
Wang, Junmei, George A. Krudy, Xiang‐Qun Xie, Chengde Wu, & George W. Holland. (2006). Genetic Algorithm-Optimized QSPR Models for Bioavailability, Protein Binding, and Urinary Excretion. Journal of Chemical Information and Modeling. 46(6). 2674–2683. 43 indexed citations
9.
Wu, Chengde, George W. Holland, Tommy A. Brock, & Richard A. F. Dixon. (2003). Recently discovered sulfonamide-, acyl sulfonamide- and carboxylic acid-based endothelin antagonists.. PubMed. 6(3). 232–9. 2 indexed citations
10.
Wu, Chengde, et al.. (2002). SELECTIVE ALKYLATION/ACYLATION OF DI- OR TRIANIONS: EXPEDITIOUS DERIVATIZATION OF ENDOTHELIN ANTAGONISTS[1]. Synthetic Communications. 32(10). 1615–1624.
11.
Perreault, Thérèse, John W. Berkenbosch, Keith J. Barrington, et al.. (2001). TBC3711, an ETA Receptor Antagonist, Reduces Neonatal Hypoxia-Induced Pulmonary Hypertension in Piglets. Pediatric Research. 50(3). 374–383. 37 indexed citations
12.
Wu, Chengde, E. Radford Decker, Huong Thi Bui, et al.. (2001). Acyl Substitution at the Ortho Position of Anilides Enhances Oral Bioavailability of Thiophene Sulfonamides:  TBC3214, an ETA Selective Endothelin Antagonist. Journal of Medicinal Chemistry. 44(8). 1211–1216. 20 indexed citations
13.
Wu, Chengde. (2000). Recent discovery and development of endothelin receptor antagonists. Expert Opinion on Therapeutic Patents. 10(11). 1653–1668. 12 indexed citations
14.
Chen, Qi, et al.. (1999). A 3D QSAR analysis ofin vitro binding affinity and selectivity of 3-isoxazolylsulfonylaminothiophenes as endothelin receptor antagonists. Quantitative Structure-Activity Relationships. 18(2). 124–133. 2 indexed citations
15.
Wu, Chengde, Ronald J. Biediger, & Timothy P. Kogan. (1999). A Highly Practical Route to 7-Hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-one fromp-Anisidine. Synthetic Communications. 29(20). 3509–3516. 3 indexed citations
16.
Chan, Ming Fai, Erik Verner, B. Raju, et al.. (1998). The discovery and structure—activity relationships of nonpeptide, low molecular weight antagonists selective for the endothelin ETB receptor. Bioorganic & Medicinal Chemistry. 6(12). 2301–2316. 23 indexed citations
17.
Wu, Chengde, Ming Fai Chan, Fiona Stavros, et al.. (1997). Discovery of TBC11251, a Potent, Long Acting, Orally Active Endothelin Receptor-A Selective Antagonist. Journal of Medicinal Chemistry. 40(11). 1690–1697. 104 indexed citations
18.
Wu, Chengde, et al.. (1997). Structure−Activity Relationships of N 2-Aryl-3-(isoxazolylsulfamoyl)-2-thiophenecarboxamides as Selective Endothelin Receptor-A Antagonists. Journal of Medicinal Chemistry. 40(11). 1682–1689. 13 indexed citations
19.
Chan, Ming Fai, B. Raju, Erik Verner, et al.. (1996). Halogen substitution at the isoxazole ring enhances the activity of N-(isoxazolyl)sulfonamide endothelin antagonists. Bioorganic & Medicinal Chemistry Letters. 6(20). 2393–2398. 8 indexed citations
20.
Raju, B., Chengde Wu, Erik Verner, et al.. (1996). Thiophenesulfonamides as endothelin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 6(22). 2651–2656. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bryan K. Sorensen Breakdown of academic impact, for papers by Nathalie Ouimet Breakdown of academic impact, for papers by Philip D. Stein Breakdown of academic impact, for papers by Steven A. Boyd Breakdown of academic impact, for papers by Gary M. Ksander Breakdown of academic impact, for papers by Friederike Stoll Breakdown of academic impact, for papers by Tram Huynh Breakdown of academic impact, for papers by Hideyuki Adachi Breakdown of academic impact, for papers by Clive McCarthy Breakdown of academic impact, for papers by Wolfgang Wostl
Rankless by CCL
2026